Quarterly Result7 Aug 2026, 05:01 pm
Gujarat Terce Laboratories Declares Unaudited Q1 FY27 Results
AI Summary
Gujarat Terce Laboratories Limited announced its Unaudited Standalone Financial Results for the first quarter ended 30 June 2026. The Board of Directors approved these results, which have undergone a Limited Review by the Statutory Auditor, Shah Doshi Patel & Associates LLP. The company prepares its financial statements in accordance with Indian Accounting Standards (Ind AS). The results are for a single segment, Pharmaceuticals.
Key Highlights
- Board approved Unaudited Standalone Financial Results for Q1 FY27.
- Results are for the quarter ended 30 June 2026.
- Limited Review conducted by Statutory Auditor.
- Company follows Ind AS accounting standards.
- Operations are in a single Pharmaceutical segment.
Price Impact
More from GUJTERC